51,250 Shares in The Cooper Companies, Inc. $COO Purchased by Munich Reinsurance Co Stock Corp in Munich

Munich Reinsurance Co Stock Corp in Munich purchased a new stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 51,250 shares of the medical device company’s stock, valued at approximately $3,666,000.

Several other large investors have also recently added to or reduced their stakes in the company. New York Life Investment Management LLC lifted its position in shares of Cooper Companies by 0.6% in the 4th quarter. New York Life Investment Management LLC now owns 27,344 shares of the medical device company’s stock worth $2,241,000 after acquiring an additional 158 shares during the period. Root Financial Partners LLC grew its holdings in shares of Cooper Companies by 104.5% during the 4th quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock worth $26,000 after purchasing an additional 162 shares in the last quarter. Allworth Financial LP increased its position in shares of Cooper Companies by 14.1% during the fourth quarter. Allworth Financial LP now owns 1,355 shares of the medical device company’s stock valued at $111,000 after purchasing an additional 167 shares during the period. Blue Trust Inc. raised its stake in shares of Cooper Companies by 13.9% in the fourth quarter. Blue Trust Inc. now owns 1,515 shares of the medical device company’s stock valued at $124,000 after purchasing an additional 185 shares in the last quarter. Finally, SJS Investment Consulting Inc. raised its stake in shares of Cooper Companies by 107.5% in the first quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company’s stock valued at $26,000 after purchasing an additional 187 shares in the last quarter. Institutional investors and hedge funds own 24.39% of the company’s stock.

Cooper Companies Stock Performance

COO stock opened at $69.61 on Thursday. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.27 and a quick ratio of 0.78. The company has a 50 day moving average price of $64.92 and a 200 day moving average price of $73.09. The Cooper Companies, Inc. has a fifty-two week low of $58.89 and a fifty-two week high of $89.83. The stock has a market capitalization of $13.58 billion, a PE ratio of 58.99, a price-to-earnings-growth ratio of 1.88 and a beta of 0.84.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings data on Thursday, June 4th. The medical device company reported $1.21 EPS for the quarter, beating analysts’ consensus estimates of $1.10 by $0.11. The firm had revenue of $1.08 billion for the quarter, compared to analyst estimates of $1.05 billion. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The business’s quarterly revenue was up 7.9% compared to the same quarter last year. During the same period last year, the company earned $0.96 EPS. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Analysts forecast that The Cooper Companies, Inc. will post 4.63 EPS for the current year.

Analyst Ratings Changes

A number of research firms have weighed in on COO. Wall Street Zen upgraded shares of Cooper Companies from a “hold” rating to a “buy” rating in a research note on Sunday, June 21st. BNP Paribas Exane dropped their price objective on Cooper Companies from $95.00 to $92.00 and set an “outperform” rating for the company in a research note on Monday, June 8th. JPMorgan Chase & Co. dropped their target price on shares of Cooper Companies from $80.00 to $71.00 and set a “neutral” rating for the company in a research report on Friday, June 5th. Robert W. Baird cut their price target on shares of Cooper Companies from $98.00 to $85.00 and set an “outperform” rating for the company in a report on Friday, June 5th. Finally, Citigroup restated a “neutral” rating and issued a $76.00 price target (up from $69.00) on shares of Cooper Companies in a research report on Wednesday. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, five have assigned a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $81.85.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.